ALB and neoplasm: Inspired by this, herein we have synthesized biocompatible BPQDs@HSA to achieve synergistic tumor inhibition by combining BPQDs‐potentiated clinical patients‐derived NK cell immunotherapy with X‐ray radiotherapy.